EDITORIAL
Published on 28 Sep 2022
Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists
doi 10.3389/fpsyt.2022.1038627
- 1,064 views
- 3 citations
- Frontiers in Psychiatry
- Psychopharmacology
- Research Topics
- Novel Antipsychotics Within and Beyond Clinical Trials: The Treatment of Overlapping Psychiatric Disorders with D3-D2 Partial Agonists
Novel Antipsychotics Within and Beyond Clinical Trials: The Treatment of Overlapping Psychiatric Disorders with D3-D2 Partial Agonists
36k
Total Downloads
199k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
CASE REPORT
Published on 01 Aug 2022
Case Report: Functional and Symptomatic Improvement With Cariprazine in Various Psychiatric Patients: A Case Series
doi 10.3389/fpsyt.2022.878889
- 2,267 views
- 4 citations
SYSTEMATIC REVIEW
Published on 24 May 2022
Brain Derived Neurotrophic Factor and Cognitive Dysfunction in the Schizophrenia-Bipolar Spectrum: A Systematic Review and Meta-Analysis
doi 10.3389/fpsyt.2022.827322
- 2,299 views
- 11 citations
BRIEF RESEARCH REPORT
Published on 11 May 2022
Cariprazine Use in Combination With a Mood Stabilizer in First Episode Mania
doi 10.3389/fpsyt.2022.828088
- 4,799 views
- 2 citations
ORIGINAL RESEARCH
Published on 11 May 2022
Remission of Persistent Negative Symptoms and Psychosocial Consequences by Combined Clozapine and Cariprazine Treatment in a Patient With Long-Standing Treatment-Resistant Schizoaffective Disorder
doi 10.3389/fpsyt.2022.887547
- 3,385 views
- 9 citations
PERSPECTIVE
Published on 27 Apr 2022
Cariprazine's Potential in Improving Social Dysfunction in Patients With Schizophrenia: A Perspective
doi 10.3389/fpsyt.2022.868751
- 3,105 views
- 3 citations
ORIGINAL RESEARCH
Published on 25 Apr 2022
Depressive Symptoms and PANSS Symptom Dimensions in Patients With Predominant Negative Symptom Schizophrenia: A Network Analysis
doi 10.3389/fpsyt.2022.795866
- 3,067 views
- 17 citations
ORIGINAL RESEARCH
Published on 25 Apr 2022
What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial
doi 10.3389/fpsyt.2022.816339
- 3,419 views
- 6 citations
REVIEW
Published on 06 Apr 2022
Molecular Imaging of Dopamine Partial Agonists in Humans: Implications for Clinical Practice
doi 10.3389/fpsyt.2022.832209
- 3,402 views
- 15 citations
REVIEW
Published on 24 Mar 2022
Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo
doi 10.3389/fpsyt.2022.785592
- 4,203 views
- 5 citations
SYSTEMATIC REVIEW
Published on 17 Mar 2022
Real-Life Clinical Experience With Cariprazine: A Systematic Review of Case Studies
doi 10.3389/fpsyt.2022.827744
- 14,113 views
- 6 citations
REVIEW
Published on 15 Mar 2022
A Complex Combination Therapy for a Complex Disease–Neuroimaging Evidence for the Effect of Music Therapy in Schizophrenia
doi 10.3389/fpsyt.2022.795344
- 4,928 views
- 5 citations
Published in
Frontiers in Psychiatry
- Psychopharmacology
Impact
- 199kTopic views
- 158kArticle views
- 36kArticle downloads